Lymphoid neogenesis and tertiary lymphoid organs in transplanted organs

Frontiers in Immunology

Volumn 7, Issue DEC, 2016, Pages

  Koenig, Alice ^a,b,c   Thaunat, Olivier ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Chronic rejection; Lymphoid neogenesis; Tertiary lymphoid organs; Tolerance; Transplantation

Indexed keywords

CD20 ANTIGEN; CXCL13 CHEMOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 27; LYMPHOTOXIN BETA RECEPTOR; PROTEIN BCL 2; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR;

ALLOGRAFT; ALLOIMMUNITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; LYMPHOID ORGAN; NONHUMAN; ORGAN TRANSPLANTATION; ORGANOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 85009348472     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00646     Document Type: Review

References (69)

1. Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 4:124ra28. doi:10.1126/scitranslmed.3003509
2. Cetrulo CL, Drijkoningen T, Sachs DH. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application? Curr Opin Organ Transplant (2015) 20:602-7. doi:10.1097/MOT.0000000000000248
3. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med (2004) 351:2715-29. doi:10.1056/NEJMra033540
4. Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2012) 12:388-99. doi:10.1111/j.1600-6143.2011.03840.x
5. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant (2011) 11:1226-35. doi:10.1111/j.1600-6143.2011.03539.x
6. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol (2004) 15:603-12. doi:10.1097/01.ASN.0000113316.52371.2E
7. Thaunat O, Field A-C, Dai J, Louedec L, Patey N, Bloch M-F, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A (2005) 102:14723-8. doi:10.1073/pnas.0507223102
8. Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol (2010) 185:717-28. doi:10.4049/jimmunol.0903589
9. Thaunat O, Patey N, Morelon E, Michel J-B, Nicoletti A. Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr Opin Immunol (2006) 18:576-9. doi:10.1016/j.coi.2006.07.006
10. Thaunat O, Nicoletti A. Lymphoid neogenesis in chronic rejection. Curr Opin Organ Transplant (2008) 13:16-9. doi:10.1097/MOT.0b013e3282f3df15
11. Wehner JR, Fox-Talbot K, Halushka MK, Ellis C, Zachary AA, Baldwin WM. B cells and plasma cells in coronaries of chronically rejected cardiac transplants. Transplantation (2010) 89:1141-8. doi:10.1097/TP.0b013e3181d3f271
12. Sato M, Hirayama S, Hwang DM, Lara-Guerra H, Wagnetz D, Waddell TK, et al. The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation. J Immunol (2009) 182:7307-16. doi:10.4049/jimmunol.0803606
13. Kanitakis J, Karayannopoulou G, Lanzetta M, Petruzzo P. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts. Transpl Int (2014) 27:e118-23. doi:10.1111/tri.12399
14. Hautz T, Zelger BG, Nasr IW, Mundinger GS, Barth RN, Rodriguez ED, et al. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts. Transpl Int (2014) 27:966-76. doi:10.1111/tri.12358
15. Thaunat O, Badet L, Dubois V, Kanitakis J, Petruzzo P, Morelon E. Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation? Curr Opin Organ Transplant (2015) 20:596-601. doi:10.1097/MOT.0000000000000242
16. Dieu-Nosjean M-C, Giraldo NA, Kaplon H, Germain C, Fridman WH, Sautès-Fridman C. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev (2016) 271:260-75. doi:10.1111/imr.12405
17. Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol (2014) 14:447-62. doi:10.1038/nri3700
18. Randall TD, Carragher DM, Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol (2008) 26:627-50. doi:10.1146/annurev.immunol.26.021607.090257
19. Van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol (2010) 10:664-74. doi:10.1038/nri2832
20. Guedj K, Khallou-Laschet J, Clement M, Morvan M, Gaston A-T, Fornasa G, et al. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res (2014) 101:434-43. doi:10.1093/cvr/cvt263
21. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, Sawa S, et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J Exp Med (2011) 208:125-34. doi:10.1084/jem.20100052
22. Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, et al. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein. J Neuroimmunol (2006) 179:76-86. doi:10.1016/j.jneuroim.2006.06.015
23. Motallebzadeh R, Rehakova S, Conlon TM, Win TS, Callaghan CJ, Goddard M, et al. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J (2012) 26:51-62. doi:10.1096/fj.11-186973
24. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol (1992) 149:3881-8.
25. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell (2001) 104:487-501. doi:10.1016/S0092-8674(01)00237-9
26. Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, Wang J, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity (2006) 25:499-509. doi:10.1016/j.immuni.2006.06.016
27. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation (1992) 53:151-6. doi:10.1097/00007890-199201000-00031
28. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity (2011) 35:986-96. doi:10.1016/j.immuni.2011.10.015
29. Fleige H, Ravens S, Moschovakis GL, Bölter J, Willenzon S, Sutter G, et al. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med (2014) 211:643-51. doi:10.1084/jem.20131737
30. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L, et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol (2011) 12:639-46. doi:10.1038/ni.2053
31. Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V, et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol (2010) 184:5344-51. doi:10.4049/jimmunol.0902999
32. Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med (2015) 212:1793-802. doi:10.1084/jem.20132307
33. Thaunat O, Graff-Dubois S, Fabien N, Duthey A, Attuil-Audenis V, Nicoletti A, et al. A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection. Kidney Int (2012) 81:207-19. doi:10.1038/ki.2011.317
34. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol (2006) 27:441-5. doi:10.1016/j.it.2006.08.003
35. Thaunat O, Graff-Dubois S, Brouard S, Gautreau C, Varthaman A, Fabien N, et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS One (2010) 5:e11398. doi:10.1371/journal.pone.0011398
36. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 352:558-69. doi:10.1056/NEJMoa035717
37. Sicard A, Chen C-C, Morelon E, Thaunat O. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection. Curr Opin Organ Transplant (2016) 21:368-74. doi:10.1097/MOT.0000000000000329
38. Carrasco YR, Batista FD. B cell recognition of membrane-bound antigen: an exquisite way of sensing ligands. Curr Opin Immunol (2006) 18:286-91. doi:10.1016/j.coi.2006.03.013
39. Sarwal M, Chua M-S, Kambham N, Hsieh S-C, Satterwhite T, Masek M, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 349:125-38. doi:10.1056/NEJMoa035588
40. Zarkhin V, Kambham N, Li L, Kwok S, Hsieh S-C, Salvatierra O, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int (2008) 74:664-73. doi:10.1038/ki.2008.249
41. Nasr IW, Reel M, Oberbarnscheidt MH, Mounzer RH, Baddoura FK, Ruddle NH, et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant (2007) 7:1071-9. doi:10.1111/j.1600-6143.2007.01756.x
42. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol (2010) 10:236-47. doi:10.1038/nri2729
43. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 1:475-82. doi:10.1038/82717
44. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, et al. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol (2007) 179:4857-66. doi:10.4049/jimmunol.179.7.4857
45. Wojciechowski W, Harris DP, Sprague F, Mousseau B, Makris M, Kusser K, et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity (2009) 30:421-33. doi:10.1016/j.immuni.2009.01.006
46. Thaunat O, Legendre C, Morelon E, Kreis H, Mamzer-Bruneel M-F. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation (2007) 84:671-6. doi:10.1097/01.tp.0000282870.71282.ed
47. Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity (2015) 42:607-12. doi:10.1016/j.immuni.2015.04.005
48. Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol (2008) 8:391-7. doi:10.1038/nri2315
49. Bouaziz J-D, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev (2008) 224:201-14. doi:10.1111/j.1600-065X.2008.00661.x
50. Thaunat O, Morelon E, Defrance T. Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood (2010) 116:515-21. doi:10.1182/blood-2010-01-266668
51. Brouard S, Pallier A, Renaudin K, Foucher Y, Danger R, Devys A, et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 12:3296-307. doi:10.1111/j.1600-6143.2012.04249.x
52. Pallier A, Hillion S, Danger R, Giral M, Racapé M, Degauque N, et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int (2010) 78:503-13. doi:10.1038/ki.2010.162
53. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 120:1836-47. doi:10.1172/JCI39933
54. Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 120:1848-61. doi:10.1172/JCI39922
55. Brown K, Sacks SH, Wong W. Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Eur J Immunol (2011) 41:89-96. doi:10.1002/eji.201040759
56. Le Texier L, Thebault P, Lavault A, Usal C, Merieau E, Quillard T, et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2011) 11:429-38. doi:10.1111/j.1600-6143.2010.03336.x
57. Li W, Bribriesco AC, Nava RG, Brescia AA, Ibricevic A, Spahn JH, et al. Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis. Mucosal Immunol (2012) 5:544-54. doi:10.1038/mi.2012.30
58. Hippen BE, DeMattos A, Cook WJ, Kew CE, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant (2005) 5:2248-52. doi:10.1111/j.1600-6143.2005.01009.x
59. Kayler LK, Lakkis FG, Morgan C, Basu A, Blisard D, Tan HP, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant (2007) 7:949-54. doi:10.1111/j.1600-6143.2007.01737.x
60. Bagnasco SM, Tsai W, Rahman MH, Kraus ES, Barisoni L, Vega R, et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant (2007) 7:1968-73. doi:10.1111/j.1600-6143.2007.01885.x
61. Scheepstra C, Bemelman FJ, van der Loos C, Rowshani AT, van Donselaar-Van der Pant KAMI, Idu MM, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation (2008) 86:772-8. doi:10.1097/TP.0b013e3181860a74
62. Hwang HS, Song JH, Hyoung BJ, Lee SY, Jeon YJ, Kang SH, et al. Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft. Transplantation (2010) 89:1489-95. doi:10.1097/TP.0b013e3181dd35b8
63. Martin L, Charon-Barra C, Bocrie O, Guignier F, D'Athis P, Dautin G, et al. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction. Transpl Immunol (2010) 22:110-4. doi:10.1016/j.trim.2009.11.001
64. Abbas K, Mubarak M, Zafar MN, Aziz T, Abbas H, Muzaffar R, et al. Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases. Clin Transplant (2015) 29:835-41. doi:10.1111/ctr.12589
65. Yamani MH, Ratliff NB, Starling RC, Tuzcu EM, Yu Y, Cook DJ, et al. Quilty lesions are associated with increased expression of vitronectin receptor (alphavbeta3) and subsequent development of coronary vasculopathy. J Heart Lung Transplant (2003) 22:687-90. doi:10.1016/S1053-2498(02)01181-6
66. Chu KE, Ho EK, de la Torre L, Vasilescu ER, Marboe CC. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation. Cardiovasc Pathol (2005) 14:219-24. doi:10.1016/j.carpath.2005.03.009
67. Hiemann NE, Knosalla C, Wellnhofer E, Lehmkuhl HB, Hetzer R, Meyer R. Quilty indicates increased risk for microvasculopathy and poor survival after heart transplantation. J Heart Lung Transplant (2008) 27:289-96. doi:10.1016/j.healun.2007.11.573
68. Zakliczynski M, Nozynski J, Konecka-Mrowka D, Pyka L, Trybunia D, Swierad M, et al. Quilty effect correlates with biopsy-proven acute cellular rejection but does not predict transplanted heart coronary artery vasculopathy. J Heart Lung Transplant (2009) 28:255-9. doi:10.1016/j.healun.2008.12.011
69. Frank R, Dean SA, Molina MR, Kamoun M, Lal P. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies. Cardiovasc Pathol (2015) 24:168-72. doi:10.1016/j.carpath.2014.11.001